A UK start-up company called GammaDelta Therapeutics Ltd has joined a small number of European companies that are exploring the potential of gamma delta T cells as the basis for new immunotherapies for cancer. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
